Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders

about

Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders

Item

http://www.wikidata.org/entity/Q39853474

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Novel Antipsychotics in the Tr ...... th Neurodegenerative Disorders

@en

Novel Antipsychotics in the Tr ...... h Neurodegenerative Disorders.

@nl

type

Item

label

Novel Antipsychotics in the Tr ...... th Neurodegenerative Disorders

@en

Novel Antipsychotics in the Tr ...... h Neurodegenerative Disorders.

@nl

prefLabel

Novel Antipsychotics in the Tr ...... th Neurodegenerative Disorders

@en

Novel Antipsychotics in the Tr ...... h Neurodegenerative Disorders.

@nl

P1476

Novel Antipsychotics in the Tr ...... th Neurodegenerative Disorders

@en

P2093

Prakash S. Masand

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropsychiatric manifestations of multiple sclerosis

Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine

Worsening of motor features of parkinsonism with olanzapine

Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment.

Management of psychotic aspects of Parkinson's disease.

Pharmacologic management of psychosis in dementia.

Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

P304

80-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/PCC.V02N0302

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15014653

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

181113

http://www.w3.org/2001/XMLSchema#string